Latest Jobs at Summit Therapeutics, Inc.

Summit Therapeutics, Inc. is a biopharmaceutical oncology company developing and commercializing medicines for serious unmet medical needs. Its lead program, ivonescimab (SMT112), is a bispecific antibody targeting PD-1 and VEGF that is being evaluated in Phase 3 clinical trials for non-small cell lung cancer and other solid tumors under license from Akeso. The company’s work spans clinical development, regulatory strategy, and potential commercialization in its licensed territories, with a focus on treatments designed to support patients and caregivers.